Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EDNRA | P25101 | 11/20 | 0.43 |
| ▸ | AGTR1 | P30556 | 3/20 | 0.43 |
| ▸ | EDNRB | P24530 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL535104 | 1.00 | EDNRA (0.43) | EDNRAAGTR1EDNRB | |
| SCHEMBL30171054 | 0.94 | EDNRA (0.41) | EDNRAAGTR1EDNRB | |
| SCHEMBL5523918 | 0.94 | EDNRA (0.41) | EDNRAAGTR1EDNRB | |
| SCHEMBL5521669 | 0.92 | EDNRA (0.36) | EDNRAAGTR1 | |
| SCHEMBL534996 | 0.92 | EDNRA (0.43) | EDNRAAGTR1EDNRB | |
| SCHEMBL26688766 | 0.92 | EDNRA (0.43) | EDNRAAGTR1EDNRB | |
| SCHEMBL30757327 | 0.92 | EDNRA (0.43) | EDNRAAGTR1EDNRB | |
| SCHEMBL4291679 | 0.92 | EDNRA (0.43) | EDNRAAGTR1EDNRB | |
| SCHEMBL15728331 | 0.90 | EDNRA (0.42) | EDNRAAGTR1EDNRB | |
| SCHEMBL26688792 | 0.90 | EDNRA (0.36) | EDNRAAGTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025094214-A1 | Process for the preparation of 2-[4-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-2-(ethoxymethyl)phenyl]-N-(4,5-dimethyl-1,2-oxazol-3-yl) benzenesulfonamide and its intermediates thereof | MSN LABORATORIES PRIVATE LIMITED, R&D CENTER (IN) | 2025-05-08 | — | — | WO | disclosed |
| WO-2023224963-A1 | DUAL-ACTING ANGIOTENSIN AND ENDOTHELIN RECEPTOR ANTAGONISTS | ARIA PHARMACEUTICALS, INC. (US) | 2023-11-23 | — | — | WO | disclosed |